Cargando…

Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design

The aim of this study was to prepare orally disintegrating tablets (ODTs) containing dexamethasone (DEX) by direct compression method with sufficient hardness and rapid disintegration time. In order to save time, money, and human resources in designing and improvement of formulation, the statistical...

Descripción completa

Detalles Bibliográficos
Autores principales: Soroush, Hadis, Ghorbani-Bidkorbeh, Fatemeh, Mortazavi, Seyed Alireza, Mehramizi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269575/
https://www.ncbi.nlm.nih.gov/pubmed/30568675
_version_ 1783376501303934976
author Soroush, Hadis
Ghorbani-Bidkorbeh, Fatemeh
Mortazavi, Seyed Alireza
Mehramizi, Ali
author_facet Soroush, Hadis
Ghorbani-Bidkorbeh, Fatemeh
Mortazavi, Seyed Alireza
Mehramizi, Ali
author_sort Soroush, Hadis
collection PubMed
description The aim of this study was to prepare orally disintegrating tablets (ODTs) containing dexamethasone (DEX) by direct compression method with sufficient hardness and rapid disintegration time. In order to save time, money, and human resources in designing and improvement of formulation, the statistical software Design Expert is used. Box–Behnken response surface methodology was applied to evaluate and optimize the effects of concentrations of three excipients, Kollidon CL-SF (X1), Pearlitol SD200 (X2), and Prosolv SMCC (X3) as independent factors on four responses: percentage of drug released after 5 min, disintegrating time, hardness, and friability. Thirteen formulations offered by the Box–Behnken design were prepared by direct compression method and ultimate weight of 200 mg, while the amount of DEX was 4 mg. All formulations were characterized for parameters such as diameter, hardness, weight, thickness, friability, and disintegration time. Following the statistical results, the effects of independent variables on responses were evaluated and the optimum formulation regarding acceptable responses consisted of 15% Kollidon, 39.66% Pearlitol, and 7.5% Prosolv which showed 95.28% release of the drug after 5 min, disintegrating time of 30 sec, 6.1 kg hardness, and 0.12% of friability with an acceptable taste as the optimized formulation.
format Online
Article
Text
id pubmed-6269575
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-62695752018-12-19 Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design Soroush, Hadis Ghorbani-Bidkorbeh, Fatemeh Mortazavi, Seyed Alireza Mehramizi, Ali Iran J Pharm Res Original Article The aim of this study was to prepare orally disintegrating tablets (ODTs) containing dexamethasone (DEX) by direct compression method with sufficient hardness and rapid disintegration time. In order to save time, money, and human resources in designing and improvement of formulation, the statistical software Design Expert is used. Box–Behnken response surface methodology was applied to evaluate and optimize the effects of concentrations of three excipients, Kollidon CL-SF (X1), Pearlitol SD200 (X2), and Prosolv SMCC (X3) as independent factors on four responses: percentage of drug released after 5 min, disintegrating time, hardness, and friability. Thirteen formulations offered by the Box–Behnken design were prepared by direct compression method and ultimate weight of 200 mg, while the amount of DEX was 4 mg. All formulations were characterized for parameters such as diameter, hardness, weight, thickness, friability, and disintegration time. Following the statistical results, the effects of independent variables on responses were evaluated and the optimum formulation regarding acceptable responses consisted of 15% Kollidon, 39.66% Pearlitol, and 7.5% Prosolv which showed 95.28% release of the drug after 5 min, disintegrating time of 30 sec, 6.1 kg hardness, and 0.12% of friability with an acceptable taste as the optimized formulation. Shaheed Beheshti University of Medical Sciences 2018 /pmc/articles/PMC6269575/ /pubmed/30568675 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Soroush, Hadis
Ghorbani-Bidkorbeh, Fatemeh
Mortazavi, Seyed Alireza
Mehramizi, Ali
Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
title Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
title_full Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
title_fullStr Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
title_full_unstemmed Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
title_short Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
title_sort formulation optimization and assessment of dexamethasone orally disintegrating tablets using box-behnken design
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269575/
https://www.ncbi.nlm.nih.gov/pubmed/30568675
work_keys_str_mv AT soroushhadis formulationoptimizationandassessmentofdexamethasoneorallydisintegratingtabletsusingboxbehnkendesign
AT ghorbanibidkorbehfatemeh formulationoptimizationandassessmentofdexamethasoneorallydisintegratingtabletsusingboxbehnkendesign
AT mortazaviseyedalireza formulationoptimizationandassessmentofdexamethasoneorallydisintegratingtabletsusingboxbehnkendesign
AT mehramiziali formulationoptimizationandassessmentofdexamethasoneorallydisintegratingtabletsusingboxbehnkendesign